Advertisement

Gene Therapy for HIV Infection

  • Clay Smith

Table of contents

  1. Front Matter
    Pages i-xvii
  2. Magnús Gottfredsson
    Pages 1-12
  3. Magnús Gottfredsson
    Pages 13-47
  4. Seong-Wook Lee, Bruce A. Sullenger
    Pages 49-58
  5. Kenneth L. Phillips
    Pages 59-75
  6. Linda M. Kofeldt, David Camerini
    Pages 119-140
  7. Clay Smith, Cristina Gasparetto
    Pages 141-176
  8. Back Matter
    Pages 177-178

About this book

Introduction

ince the early 1980s, the HIV epidemic has been raging within the S 1 United States and around the world. Drug therapy for HIV infection has not been curative, prompting the search for alternative strategies to control HIV infection within infected persons. One potential alterna­ tive to drug therapy is a developing medical technology termed gene therapy. 2 Gene therapy involves introducing genetic elements into popu­ lations of cells in order to correct or prevent a pathologic process. A large number of gene therapy strategies have been developed in an at­ tempt to inhibit HIV expression and spread. These strategies fall into two general categories, genetic modification of cells in order to elicit an immune response against HIV and genetic modification of the target cells of HIV infection in order to block HIV expression and reproduction. In the first strategy, termed genetic immunotherapy by some, genetic material encoding HIV proteins is introduced into patient's cells in order to stimulate a cellular immune response above and beyond 3 5 that stimulated by the viral infection itself. - Two general genetic im­ munotherapy strategies have been developed. Genes encoding HIV pro­ teins have been directly injected into the dermis or muscle tissue of patients. These genes have been encoded in plasmids or viral DNA and have been injected either in the form of naked DNA or complexed with lipids.

Keywords

AIDS HIV Immunsystem diseases gene therapy gene transfer hematopoietic stem cell hematopoietic stem cell transplantation immune system infection infectious disease lymphocytes stem cell transplantation stem cells transplantation

Authors and affiliations

  • Clay Smith
    • 1
  1. 1.Bone Marrow Transplantation ProgramDuke University Medical CenterDurhamUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-662-11821-4
  • Copyright Information Springer-Verlag Berlin Heidelberg 1998
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-662-11823-8
  • Online ISBN 978-3-662-11821-4
  • Buy this book on publisher's site